Genetic Predisposition to Neuroleptic Malignant Syndrome in Siblings

Abstract

Get full access to this article

View all access options for this article.

References

Caroff

Mann

. Neuroleptic malignant syndrome. Med Clin North Am 1993;77:185–202.

Ananth

Parameswaran

Gunatilake

Burgoyne

Sidhom

. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 2004;65:464–70.

Rosenberg

Green

. Neuroleptic malignant syndrome: review of response to therapy. Arch Intern Med 1989;149:1927–31.

Kawanishi

. Genetic predispositions to neuroleptic malignant syndrome: implications for antipsychotic therapy. Am J Pharmacogenomics 2003;3:89–95.

Kishida

Kawanishi

Furuno

Kato

Ishigami

Kosaka

. Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D₂ receptor gene. Mol Psychiatry 2004;9:293–8.

Diagnostic and statistical manual of mental disorders. 4th rev. Washington, DC: American Psychiatric Association, 2000.

Naranjo

Busto

Sellers

. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.